Ptc Therapeutics (PTCT) Inventory Average (2017 - 2026)

Ptc Therapeutics' Inventory Average history runs 10 years deep, the most recent figure standing at $83.5 million for Q2 2026.

• In Q2 2026, Inventory Average rose 199.49% year-over-year to $83.5 million; the TTM figure through Jun 2026 stood at $83.5 million (up 199.49% YoY), while the FY2025 annual figure was $51.4 million, up 91.26% from the prior year.
• Inventory Average for Q2 2026 stood at $83.5 million, up from $77.6 million in the prior quarter.
• The five-year high for Inventory Average was $83.5 million in Q2 2026, with the low at $14.9 million in Q3 2022.
• The 5-year median for Inventory Average is $29.9 million (2024), against an average of $35.0 million.
• The sharpest annual moves came in 2025 and 2026: Inventory Average fell 26.0% in 2025, then surged 245.93% in 2026.
• Ptc Therapeutics' Inventory Average stood at $18.3 million in 2022, then jumped by 81.13% to $33.2 million in 2023, then fell by 11.25% to $29.4 million in 2024, then jumped by 124.81% to $66.2 million in 2025, then rose by 26.14% to $83.5 million in 2026.
• Business Quant data shows PTCT's Inventory Average at $83.5 million in Q2 2026, $77.6 million in Q1 2026, and $66.2 million in Q4 2025.